Identification of CD8 T-Lymphocyte Epitopes in OmpB ofRickettsia conorii
Open Access
- 1 July 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (7), 3920-3926
- https://doi.org/10.1128/iai.71.7.3920-3926.2003
Abstract
The 1.2-kb DNA fragment of the Rickettsia conorii outer membrane protein B gene (OmpB451-846) was subcloned using site-specific PCR primers and expressed as six smaller fragments: OmpB458-652, OmpB595-744, OmpB595-654, OmpB645-692, OmpB689-744, and OmpB739-848. NCTC cells transfected with a mammalian expression vector expressing the fragments OmpB689-744 and OmpB739-848 stimulated immune anti-R. conorii CD8 T lymphocytes, suggesting the presence of CD8 T-lymphocyte-stimulating epitopes on these fragments. In order to further characterize the CD8 T-lymphocyte-stimulatory elements, CD8 T-lymphocyte epitopes on OmpB689-744 and OmpB739-848 were mapped by overlapping synthetic peptides. The ability of these synthetic peptides to stimulate immune CD8 T lymphocytes was determined by gamma interferon (IFN-γ) production and cell proliferation after incubation with simian virus 40-transformed murine vascular endothelial cells in the presence of a 20 μM solution of each synthetic peptide. Five synthetic peptides, SKGVNVDTV (OmpB708-716), ANVGSFVFN (OmpB735-743), IVSGTVGGQ (OmpB749-757), ANSTLQIGG (OmpB789-797), and IVEFVNTGP (OmpB812-820), induced secretion of IFN-γ at significantly higher levels than the controls. Three of these five peptides, SKGVNVDTV (OmpB708-716), ANSTLQIGG (OmpB789-797), and IVEFVNTGP (OmpB812-820), also stimulated the proliferation of immune CD8 T lymphocytes. Significantly higher levels of specific cytotoxic T-lymphocyte killing were observed with the same three synthetic peptides, SKGVNVDTV (OmpB708-716), ANSTLQIGG (OmpB789-797), and IVEFVNTGP (OmpB812-820).Keywords
This publication has 59 references indexed in Scilit:
- Critical Role of Cytotoxic T Lymphocytes in Immune Clearance of Rickettsial InfectionInfection and Immunity, 2001
- Protection of guinea-pigs from experimental Rocky Mountain spotted fever by immunization with baculovirus-expressed Rickettsia rickettsii rOmpA proteinVaccine, 1995
- Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenesNature, 1991
- The Role of Host Factors in the Severity of Spotted Fever and Typhus RickettsiosesAnnals of the New York Academy of Sciences, 1990
- Incidence, clinical observations and risk factors in the severe form of mediterranean spotted fever among patients admitted to hospital in Marseilles 1983–1984Journal of Infection, 1986
- Reactogenicity, Immunogenicity, and Efficacy of a Chick Embryo Cell-Derived Vaccine for Rocky Mountain Spotted FeverThe Journal of Infectious Diseases, 1983
- Use of Yolk Sac of Developing Chick Embryo as Medium for Growing Rickettsiae of Rocky Mountain Spotted Fever and Typhus GroupsPublic Health Reports (1896-1970), 1938
- Rocky Mountain Spotted Fever: Vaccination of Monkeys and ManPublic Health Reports (1896-1970), 1925
- Studies on Immunity in Rocky Mountain Spotted Fever. First CommunicationThe Journal of Infectious Diseases, 1908